Scarica l'app Stockscreener
11.19
6.88%
0.72
Pre-mercato:
11.78
0.59
+5.27%
Precedente Chiudi:
$10.47
Aprire:
$10.55
Volume 24 ore:
226.82K
Relative Volume:
1.21
Capitalizzazione di mercato:
$265.42M
Reddito:
$315.66M
Utile/perdita netta:
$-102.45M
Rapporto P/E:
-2.5374
EPS:
-4.41
Flusso di cassa netto:
$-30.25M
1 W Prestazione:
+5.37%
1M Prestazione:
+31.96%
6M Prestazione:
+20.97%
1 anno Prestazione:
+109.16%
Intervallo 1D:
$10.50
$11.26
Intervallo di 1 settimana:
$10.28
$11.26
Portata 52W:
$5.27
$13.33
Inogen Inc Stock (INGN) Company Profile
Nome
Inogen Inc
Settore
Industria
Telefono
805-562-0500
Indirizzo
859 WARD DRIVE, GOLETA, CA
Confronta INGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INGN
Inogen Inc
|
11.19 | 265.42M | 315.66M | -102.45M | -30.25M | -4.41 |
|
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-02-15 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2023-08-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2023-07-14 | Downgrade | Needham | Buy → Hold |
| 2023-01-17 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-12-09 | Aggiornamento | Needham | Hold → Buy |
| 2021-11-02 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2021-08-05 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-06-04 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2020-12-14 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-23 | Downgrade | Needham | Buy → Hold |
| 2020-05-06 | Reiterato | Needham | Buy |
| 2019-11-06 | Aggiornamento | Needham | Hold → Buy |
| 2019-09-13 | Reiterato | Piper Jaffray | Overweight |
| 2019-08-08 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2019-08-08 | Downgrade | Stifel | Buy → Hold |
| 2019-08-07 | Downgrade | Needham | Buy → Hold |
| 2019-06-28 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-05-08 | Reiterato | Needham | Strong Buy |
| 2019-02-27 | Reiterato | Needham | Strong Buy |
| 2018-11-20 | Aggiornamento | Needham | Buy → Strong Buy |
| 2018-11-07 | Reiterato | Needham | Buy |
| 2018-09-10 | Downgrade | Needham | Strong Buy → Buy |
| 2018-08-22 | Ripresa | Stifel | Buy |
| 2018-08-08 | Reiterato | Needham | Strong Buy |
| 2018-06-06 | Iniziato | KeyBanc Capital Mkts | Sector Weight |
| 2018-05-01 | Reiterato | Needham | Strong Buy |
| 2018-02-28 | Reiterato | Needham | Strong Buy |
Mostra tutto
Inogen Inc Borsa (INGN) Ultime notizie
Inogen, Inc. (NASDAQ:INGN) Held Back By Insufficient Growth Even After Shares Climb 32% - Simply Wall St
Inogen, Inc. (NASDAQ:INGN) Short Interest Down 6.2% in December - MarketBeat
Inogen Stock Gains Following Solid Preliminary Q4 Revenues - MSN
Barclays PLC Purchases 23,398 Shares of Inogen, Inc. (NASDAQ:INGN) - Defense World
Inogen Insiders Benefitted From Selling Stock At US$8.56 - Simply Wall St
Inogen expects prelim Q4 revenue in the range of $79M to $80M - MSN
Inogen stock holds as revenue forecast beats consensus - Investing.com India
Inogen reports growth in Q4 and full year 2024 revenue By Investing.com - Investing.com Australia
Inogen stock holds as revenue forecast beats consensus By Investing.com - Investing.com Australia
Inogen (NASDAQ:INGN) Given "Hold" Rating at Needham & Company LLC - MarketBeat
Inogen, Inc. Provides Revenue Guidance for the Fourth Quarter of 2024 and Full Year 2024 - Marketscreener.com
Inogen, Inc. (NASDAQ:INGN) Stock Position Increased by JPMorgan Chase & Co. - Defense World
Inogen (NASDAQ:INGN) Stock Crosses Above Fifty Day Moving AverageHere's Why - MarketBeat
Inogen (NASDAQ:INGN) Stock Crosses Above Fifty Day Moving Average – Here’s Why - Defense World
Inogen reports growth in Q4 and full year 2024 revenue - Investing.com India
Inogen Surpasses 2024 Revenue Guidance with 6% Growth, Launches New Respiratory Products - StockTitan
Inogen receives FDA 510(k) clearance for SIMEOX 200 airway clearance device - News-Medical.Net
Jane Street Group LLC Cuts Stake in Inogen, Inc. (NASDAQ:INGN) - Defense World
Jane Street Group LLC Sells 250,473 Shares of Inogen, Inc. (NASDAQ:INGN) - MarketBeat
Geode Capital Management LLC Purchases 5,921 Shares of Inogen, Inc. (NASDAQ:INGN) - Defense World
Franklin Resources Inc. Takes $139,000 Position in Inogen, Inc. (NASDAQ:INGN) - Defense World
Inogen, Inc. (NASDAQ:INGN) Shares Purchased by Barclays PLC - Defense World
FDA OKs Inogen’s Simeox 200 Airway Clearance Device - MPO-mag
Inogen Stock Rises as FDA Clears SIMEOX 200 Airway Clearance Device - MSN
Inogen Expands U.S. Market with FDA Clearance - Yahoo Finance
FDA grants clearance for Inogen’s SIMEOX 200 airway clearance device - Yahoo Finance
Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device - BioSpace
Inogen Gets FDA Clearance for Airway Clearance Device - MarketWatch
Inogen, Inc. (NASDAQ:INGN) Shares Purchased by State Street Corp - Defense World
Inogen's SIMEOX 200 Airway Clearance Device Receives FDA Clearance for Chronic Lung Disease Treatment - StockTitan
Here's Why You Should Retain Inogen Stock in Your Portfolio Now - Nasdaq
StockNews.com Downgrades Inogen (NASDAQ:INGN) to Hold - Defense World
Inogen, Inc. (NASDAQ:INGN) is a favorite amongst institutional investors who own 78% - Yahoo Finance
Inogen, Inc.'s (NASDAQ:INGN) institutional investors lost 12% over the past week but have profited from longer-term gains - Simply Wall St
Short Interest in Inogen, Inc. (NASDAQ:INGN) Grows By 6.7% - MarketBeat
BNP Paribas Financial Markets Increases Stock Position in Inogen, Inc. (NASDAQ:INGN) - Defense World
Inogen (NASDAQ:INGN) Raised to Buy at StockNews.com - Defense World
Respiratory Care Market Set to Witness Significant Growth by 2024-2031:Inogen, Inc., Honeywell International - EIN News
The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen - Yahoo Finance
Oxygen Concentrators Global Market Report: Market - openPR
Inogen Alliance Releases 2023 ESG Report - AccessWire
Respiratory Care Market Projected To Witness Substantial Growth, 2024-2031: Inogen, Inc., Honeywell - EIN News
Inogen (INGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - MSN
INGN (Inogen) Earnings per Share (Diluted) : $-2.25 (TTM As of Sep. 2024) - GuruFocus.com
Connor Clark & Lunn Investment Management Ltd. Buys 132,287 Shares of Inogen, Inc. (NASDAQ:INGN) - MarketBeat
Inogen Inc Azioni (INGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Inogen Inc Azioni (INGN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Ramade Gregoire | Chief Commercial Officer |
Dec 01 '24 |
Option Exercise |
0.00 |
31,565 |
0 |
31,565 |
3.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):